newsfilter
← Latest News
Business Wire·

World's First Patient Implanted with Impella BTR Minimally Invasive Heart Pump

Abiomed (NASDAQ:ABMD) announces the first patient in the world has been successfully implanted with Impella Bridge-to-Recovery (BTR) as part of the heart pump's U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS). The first implant was